Luven Diagnostic

The LUVEN screening test method created by the scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development. For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cytomorphological and cytobiophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method. A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer. A great success in this medical field opened a door to new possibilities, including cancer prevention and therapy. Don't miss your chance to join our LUCRATIVE PROJECT in promoting a unique cancer diagnostic technology designed to save millions of lives. Let's do it together! preICO Start: 08.12.2017 12:00 GMT Completion: 29.12.2017 12:00 GMT ICO Start: 15.01.2018 12:00 GMT Completion: 28.02.2018 12:00 GMT

• Employees 4